Pre-Analytical and Clinical Validation of a Dried Blood Spot Assay for Asymmetric Dimethylarginine and L-Arginine

Pre-Analytical and Clinical Validation of a Dried Blood Spot Assay for Asymmetric Dimethylarginine and L-Arginine

Asymmetric dimethylarginine (ADMA) inhibits nitric oxide (NO) synthesis. It is a risk marker for cardiovascular events and mortality in patients with cardiometabolic diseases and in population-based studies. Plasma or serum analysis of ADMA may be hampered by pre-analytical sample handling. We valid...

Full description

Bibliographic Details
Main Authors: Juliane Hannemann, Thore I. Roskam, Ina Eilermann, Patricia Siques, Julio Brito, Rainer Böger
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Journal of Clinical Medicine
Subjects:
ADMA
L-arginine
risk factor
biomarker
chronic-intermittent hypoxia
ELISA
Online Access:https://www.mdpi.com/2077-0383/9/4/1072

Internet

https://www.mdpi.com/2077-0383/9/4/1072

Similar Items